InsidersTradesSigma
Discover the full directors' dealings record of 恩华药业, a publicly traded company based in France. Shares are quoted on FR FR, under the supervision of AMF. Operating in the Health Care sector, 恩华药业 has logged 2 insider filings. Market capitalisation: €24.5bn. The latest transaction was disclosed on 22 April 2026 (Purchase). Among the most active insiders: 孙彭生. All data is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.